1,076 results
Page 3 of 54
6-K
EX-99.1
4iy2l8m 7ywzgh2y78
27 Sep 23
Current report (foreign)
6:06am
6-K
EX-99.1
zav8xn5fxfr0brgkq
5 Sep 23
Sanofi announces changes to its Executive Committee
6:19am
6-K
EX-99.1
tpn ti281s28
10 Aug 23
Recommendation for use in all infants below 8 months of age follows earlier than anticipated FDA approval and unanimous FDA Advisory Committee vote
9:50am
6-K
EX-99.1
8j7si1 zhxv
28 Jul 23
Solid Q2 performance and strong pipeline momentum
3:35pm
6-K
EX-99.1
b17k kodncc7
28 Jul 23
Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment
9:18am
6-K
EX-99.1
vu1aph 3g
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
6-K
EX-99.2
jw3e83krlztj6o
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
6-K
EX-99.1
i2whkqv7cq4qca049
24 Jul 23
FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
12:43pm
6-K
EX-99.2
8mbdf
5 Jul 23
Current report (foreign)
8:43am
6-K
EX-99.1
oh24iw9q07f25tf8jqo
5 Jul 23
Current report (foreign)
8:43am
6-K
EX-99.3
70qfpnr3ryinr415dk4
5 Jul 23
Current report (foreign)
8:43am
6-K
EX-99.1
pyubx
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.4
7si4a hv9qu
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.2
na8y5z0t94416nbuggm
2 Jun 23
Approval of the financial statements for the fiscal year 2022
10:53am
6-K
EX-99.2
cb7ehgn
23 May 23
Current report (foreign)
1:01pm
6-K
EX-99.1
6brv35esbgr7
23 May 23
Current report (foreign)
1:01pm
6-K
EX-99.1
qg6c8yanl rhahmes1jm
27 Apr 23
Strong Q1 growth driven by Specialty Care, Vaccines and CHC
11:39am
6-K
EX-99.2
gcebtw
27 Apr 23
Current report (foreign)
9:32am
6-K
EX-99.1
psod4a3nb4zmq
27 Apr 23
Current report (foreign)
9:32am
SC TO-T/A
EX-99
thddgi07v8qpq
26 Apr 23
Third party tender offer statement (amended)
6:16am